Prognostic Impact of Tumor Markers (CEA and CA19-9) on Patients with Resectable Colorectal Liver Metastases Stratified by Tumor Number and Size: Potentially Valuable Biologic Markers for Preoperative Treatment

[1]  A. Saiura,et al.  Optimizing the selection of technically unresectable colorectal liver metastases. , 2022, Surgery.

[2]  A. Saiura,et al.  Limited Prognostic Value of KRAS in Patients Undergoing Hepatectomy for Colorectal Liver Metastases , 2021, Annals of Surgical Oncology.

[3]  T. Ishizawa,et al.  Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases , 2019, World Journal of Surgical Oncology.

[4]  Z. Pan,et al.  High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection , 2016, Medical Oncology.

[5]  S. Kawasaki,et al.  Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial , 2016, PloS one.

[6]  J. Vauthey,et al.  Meta‐analysis of KRAS mutations and survival after resection of colorectal liver metastases , 2015, The British journal of surgery.

[7]  C. Verhoef,et al.  The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  L. Capussotti,et al.  Role of neoadjuvant chemotherapy in resectable synchronous colorectal liver metastasis; An international multi‐center data analysis using LiverMetSurvey , 2015, Journal of surgical oncology.

[9]  A. Saiura,et al.  Usefulness of Contrast-Enhanced Intraoperative Ultrasound in Identifying Disappearing Liver Metastases from Colorectal Carcinoma After Chemotherapy , 2014, Annals of Surgical Oncology.

[10]  G. Poston,et al.  Perioperative chemotherapy for resectable colorectal liver metastases: where now? , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[11]  J. Shindoh,et al.  Optimal Future Liver Remnant in Patients Treated with Extensive Preoperative Chemotherapy for Colorectal Liver Metastases , 2013, Annals of Surgical Oncology.

[12]  E. Van Cutsem,et al.  The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. , 2012, The oncologist.

[13]  M. Makuuchi,et al.  Liver Resection for Multiple Colorectal Liver Metastases with Surgery Up-front Approach: Bi-institutional Analysis of 736 Consecutive Cases , 2012, World Journal of Surgery.

[14]  G. Honda,et al.  A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery , 2012, Journal of hepato-biliary-pancreatic sciences.

[15]  T. Gruenberger,et al.  Sinusoidal Obstruction Syndrome Impairs Long-Term Outcome of Colorectal Liver Metastases Treated with Resection after Neoadjuvant Chemotherapy , 2011, Annals of Surgical Oncology.

[16]  Bernard Paule,et al.  Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy: A Model to Predict Long-term Survival , 2004, Annals of surgery.

[17]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[18]  L H Blumgart,et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.